ROZLET 2.5 MG FILM COATED 10 TABLET -WASFATY
ROZLET 2.5 MG FILM COATED 10 TABLET
ROZLET 2.5 MG FILM COATED TABLET contains Letrozole, an advanced medication primarily indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women. This powerful aromatase inhibitor works by significantly reducing estrogen levels in the body, thereby hindering the growth of estrogen-sensitive tumors.
Known for its efficacy, ROZLET is a crucial part of comprehensive cancer treatment plans. While primarily used for oncology, it is also sometimes employed off-label under strict medical supervision for specific fertility treatments.
Product Details
Form: Film-Coated Tablets
Active Ingredient: Letrozole 2.5 mg
Pack Size: 10 Tablets
Manufacturer: Julphar (Gulf Pharmaceutical Industries)
Drug Type: Prescription Only Medicine
Benefits of Use
- Effectively treats hormone receptor-positive breast cancer in postmenopausal women.
- Lowers estrogen levels, which helps inhibit the growth of estrogen-dependent tumors.
- Can be used as adjuvant therapy after initial treatment or for advanced stages of breast cancer.
- May be considered for specific off-label fertility treatments under expert medical guidance.
How to Use
- Always take ROZLET exactly as prescribed by your doctor.
- The typical dose is one 2.5 mg tablet once daily.
- Swallow the tablet whole with a glass of water, with or without food.
- Do not stop taking the medication or alter your dose without consulting your doctor, as treatment may be long-term.
- Ensure regular follow-up appointments with your healthcare provider to monitor treatment progress and manage any potential side effects.
Ingredients
Active ingredient: Letrozole 2.5 mg.
Contains other inactive ingredients (excipients) necessary for tablet formulation, such as lactose monohydrate, microcrystalline cellulose, maize starch, sodium starch glycolate, magnesium stearate, colloidal anhydrous silica, hypromellose, macrogol, talc, titanium dioxide (E171), and iron oxide yellow (E172).
Caution & Warnings
- ROZLET is a prescription medication; use under strict medical supervision.
- Not for use in premenopausal women, pregnant women, or those who are breastfeeding.
- Common side effects include hot flashes, nausea, fatigue, headache, dizziness, bone pain, joint pain, and hair thinning.
- May increase the risk of bone thinning (osteoporosis); bone mineral density may be monitored by your doctor.
- Exercise caution when driving or operating machinery if you experience dizziness, tiredness, or blurred vision.
- Inform your doctor about all other medications, supplements, and herbal products you are taking to avoid potential interactions.
- Patients with severe liver or kidney impairment should use this medication with caution and under close medical supervision.
Storage
Store ROZLET below 30°C.
Keep the medication out of the reach and sight of children.
Do not use the product after the expiry date indicated on the packaging.
Store in the original package to protect from moisture.
| Gtin | 10101100463000OOO |
|---|---|
| Recommended Sale Price | 56.2 |
| Is Wasfaty Product | No |
| Brand | ROZLET |
| Principle | Letrozole |
| Ingredient Name | LETROZOLE |
| SFDA Reg. No | 413-212-19 |
| IBC | 10101100463000OOO |
| Drug Type | Prescription |
| Scientific Name | Letrozole |
| Strength | 2.5 MG |
| Strength Unit | MG |
| Form | Film Coated Tablet |
| Admin Route | Oral |
| Size | 10 |
| Size Unit | Tablet |
| Package Types | Blister pack |
| Package Size | 10 Tablets |
| shelfLife | 24 months |
| Storage conditions | Store below 25°C, protected from moisture and light. |
| Refrigerator Storage | No |
| Distribute area | Saudi Arabia |
